pathway was established by FDA as a tool to encourage further development of antibacterial and antifungal drugs to treat serious, life-threatening infections that affect a limited population of patients with unmet needs.
Arikayce (amikacin liposome inhalation suspension) is the first drug to be approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs, or LPAD
pathway, established by Congress under the 21st Century Cures Act.
Univariate and multivariate analyses for factors associated to LP and LPAD
(1987), "Prerequisites for Assessment of Learning Potential: The LPAD
model" in Lidz, C.
Burns and colleagues integrated the LPAD
developed by Feuerstein (1979) and the graduated prompting assessment model established by Campione and Brown (1987) to construct the continuum of assessment model.
For example, some evidence from South Africa suggests that "dynamic mediation" with the Learning Propensity Assessment Device (LPAD
; Feuerstein, 1980) has improved the performance of Black secondary school students on Raven's SPM.
The Learning Potential Assessment Devise (LPAD
) is theoretically related to the work of Vygotsky (1978) concerning the concept of "zone of proximal development" (zpd) in which the interactions that take place between more and less capable peers or adults and children can have a significant impact on learning.
One emphasizes clinical probing of a student's readiness to master new skills, as with the Learning Potential Assessment Device (LPAD
) (Feuerstein, 1979).